Monalisa Parija^1,2 and Sandip K Mishra¹*

¹Cancer Biology Lab, Gene Function and Regulation Group, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India
²Regional Centre for Biotechnology, NCR Biotech Science Cluster, Haryana (NCR Delhi), India

*Corresponding Author: Sandip K Mishra, Cancer Biology Lab, Gene Function and Regulation Group, Institute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.

Received: May 03, 2023; Published: May 29, 2023

Abstract

Reactive oxygen species (ROS), a component of free radicals has emerged as a potential target that can elicit a cascade of cell cycle regulatory events to facilitate tumor progression. Recent reports suggest G-protein coupled receptors (GPCRs) mediated ROS activation promotes deregulated cellular signaling. Melittin, a bee venom product competently targets ROS-mediated signaling such as GPCR, mitogen-activated protein kinase (MAPK), and nuclear factor-κB (NF-κB) signaling pathways, which will eventually lead to regression in tumor development. Soaring interests toward natural anticancer drugs, Bee venom is on the bright side for future use in clinical practices when coupled with nanoparticles and other therapeutic agents. Melittin can further provide a potent system for better drug delivery to the targeted tumor. This review enlightens the efficacy of bee venom and melittin to hinder ROS-mediated tumor progression.

 Keywords: Reactive Oxygen Species; G Protein Coupled Receptors; Cell Signaling; Bee Venom; Melittin; Cancer

References

1. Shelburne Nonniekaye., et al. "Cancer treatment–related cardiotoxicity: current state of knowledge and future research priorities”. JNCI: Journal of the National Cancer Institute9 (2014).
2. Pierce Kristen L., et al. "Seven-transmembrane receptors”. Nature reviews Molecular Cell Biology9 (2002): 639-650.
3. Patel Tarun B. "Single transmembrane spanning heterotrimeric g protein-coupled receptors and their signaling cascades”. Pharmacological Reviews3 (2004): 371-385.
4. Fraser Christopher C. "G Protein–Coupled Receptor Connectivity to NF-κB in Inflammation and Cancer”. International Reviews of Immunology5 (2008): 320-350.
5. Förstermann Ulrich., et al. "Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis”. Circulation Research4 (2017): 713-735.
6. Mohamed Raafat., et al. "GPCR transactivation signalling in vascular smooth muscle cells: role of NADPH oxidases and reactive oxygen species”. Vascular Biology1 (2019): R1.
7. Lim Haet Nim., et al. "Bee venom and its peptide component melittin suppress growth and migration of melanoma cells via inhibition of PI3K/AKT/mTOR and MAPK pathways”. Molecules5 (2019): 929.
8. ŞENGÜL Fatma and Hüsamettin VATANSEV. "Overview of apitherapy products: anti-cancer effects of bee venom used in apitherapy”. International Journal of Traditional and Complementary Medicine Research1 (2021): 36-48.
9. Spiegelberg Bryan D and Heidi E Hamm. "Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription”. Current Opinion in Genetics and Development1 (2007): 40-44.
10. Audet, Martin, and Michel Bouvier. "Restructuring G-protein-coupled receptor activation”. Cell1 (2012): 14-23.
11. Neves Susana R., et al. "G protein pathways”. Science5573 (2002): 1636-1639.
12. Tuteja Narendra. "Signaling through G protein coupled receptors”. Plant Signaling and Behavior10 (2009): 942-947.
13. Ford Carolyn E., et al. "Molecular basis for interactions of G protein βγ subunits with effectors”. Science5367 (1998): 1271-1274.
14. O'Hayre Morgan., et al. "Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment”. Biochemical Journal3 (2008): 635-649.
15. Zlotnik Albert., et al. "Homeostatic chemokine receptors and organ-specific metastasis”. Nature Reviews Immunology9 (2011): 597-606.
16. Dorsam Robert T and J Silvio Gutkind. "G-protein-coupled receptors and cancer”. Nature Reviews Cancer2 (2007): 79-94.
17. Richard Darren E., et al. "Angiogenesis and G-protein-coupled receptors: signals that bridge the gap”. Oncogene13 (2001): 1556-1562.
18. Liou Geou-Yarh and Peter Storz. "Reactive oxygen species in cancer”. Free Radical Research5 (2010): 479-496.
19. Thannickal Victor J and Barry L Fanburg. "Reactive oxygen species in cell signaling”. American Journal of Physiology-Lung Cellular and Molecular Physiology6 (2000): L1005-L1028.
20. De Jager T L., et al. "Ultraviolet light induced generation of reactive oxygen species”. Ultraviolet Light in Human Health, Diseases and Environment (2017): 15-23.
21. Moriyama Akihiro., et al. "Screening of X-ray responsive substances for the next generation of radiosensitizers”. Scientific Reports1 (2019): 18163.
22. Liu Zewen., et al. "Role of ROS and nutritional antioxidants in human diseases”. Frontiers in physiology9 (2018): 477.
23. Redza-Dutordoir Maureen and Diana A Averill-Bates. "Activation of apoptosis signalling pathways by reactive oxygen species”. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research12 (2016): 2977-2992.
24. Nicholson Robert Ian., et al. "EGFR and cancer prognosis”. European Journal of Cancer37 (2001): 9-15.
25. Huo Yanan., et al. "Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing”. Experimental Eye Research6 (2009): 876-886.
26. Mitsudomi Tetsuya and Yasushi Yatabe. "Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer”. The FEBS Journal2 (2010): 301-308.
27. Burch Micah L., et al. "Thrombin-mediated proteoglycan synthesis utilizes both protein-tyrosine kinase and serine/threonine kinase receptor transactivation in vascular smooth muscle cells”. Journal of Biological Chemistry10 (2013): 7410-7419.
28. Morgan Michael J and Zheng-gang Liu. "Crosstalk of reactive oxygen species and NF-κB signaling”. Cell Research1 (2011): 103-115.
29. Wehbe Rim., et al. "Bee venom: Overview of main compounds and bioactivities for therapeutic interests”. Molecules16 (2019): 2997.
30. Ullah Amjad., et al. "Pharmacological properties and therapeutic potential of honey bee venom”. Saudi Pharmaceutical Journal (2022).
31. Liu Xing., et al. "Effect of honey bee venom on proliferation of K1735M2 mouse melanoma cells in‐vitro and growth of murine B16 melanomas in‐vivo”. Journal of Pharmacy and Pharmacology8 (2002): 1083-1089.
32. Orsolić N., et al. "Influence of honey bee products on transplantable murine tumours”. Veterinary and Comparative Oncology4 (2003): 216-226.
33. Oršolić Nada., et al. "Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom”. Toxicon7 (2003): 861-870.
34. Moon Dong-Oh., et al. "Key regulators in bee venom-induced apoptosis are Bcl-2 and caspase-3 in human leukemic U937 cells through downregulation of ERK and Akt”. International Immunopharmacology12 (2006): 1796-1807.
35. Nam Kung-Woo., et al. "Inhibition of COX-2 activity and proinflammatory cytokines (TNF-α and IL-1β) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom”. Archives of Pharmacal Research26 (2003): 383-388.
36. Shiassi Arani Faranak., et al. "Antimutagenic and synergistic cytotoxic effect of cisplatin and honey bee venom on 4T1 invasive mammary carcinoma cell line”. Advances in Pharmacological Sciences2019 (2019).  
37. Gajski Goran and Vera Garaj-Vrhovac. "Radioprotective effects of honeybee venom (Apis mellifera) against 915-mhz microwave radiation–induced DNA damage in wistar rat lymphocytes: In vitro study”. International Journal of Toxicology2 (2009): 88-98.
38. Meligi Noha M., et al. "Protective effects of honey and bee venom against lipopolysaccharide and carbon tetrachloride-induced hepatoxicity and lipid peroxidation in rats”. Toxicology Research5 (2020): 693-705.
39. Jeong Yun-Jeong., et al. "Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells”. Food and Chemical Toxicology68 (2014): 218-225.
40. Liu Shujing., et al. "Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway”. Hepatology6 (2008): 1964-1973.
41. Somwongin Suvimol., et al. "Antioxidant activity and irritation property of venoms from Apis species”. Toxicon145 (2018): 32-39.
42. Huh Jeong-Eun., et al. "Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice”. Cancer Letters1 (2010): 98-110.
43. Cho Hyun-Ji., et al. "Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK/p38 and NF-κB-dependent mechanisms”. Journal of Ethnopharmacology3 (2010): 662-668.
44. Huh Jeong-Eun., et al. "Melittin suppresses VEGF-A-induced tumor growth by blocking VEGFR-2 and the COX-2-mediated MAPK signaling pathway”. Journal of Natural Products11 (2012): 1922-1929.
45. Borojeni Sima Khalilifard., et al. "Cytotoxic effect of bee (A. mellifera) venom on cancer cell lines”. Journal of Pharmacopuncture4 (2020): 212.
46. Duffy Ciara., et al. "Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer”. NPJ Precision Oncology1 (2020): 24.
47. Sisakht Mohsen., et al. "Bee venom induces apoptosis and suppresses matrix metaloprotease-2 expression in human glioblastoma cells”. Revista Brasileira de Farmacognosia27 (2017): 324-328.
48. Tu Wu-Chun., et al. "Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells”. Toxicon2 (2008): 318-329.
49. Amini Elaheh., et al. "Cytotoxic and pro-apoptotic effects of honey bee venom and chrysin on human ovarian cancer cells”. Asia Pacific Journal of Medical Toxicology2 (2015): 68-73.
50. Ceremuga Michal., et al. "Melittin—a natural peptide from bee venom which induces apoptosis in human leukaemia cells”. Biomolecules2 (2020): 247.
51. Zheng Jie., et al. "Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B”. Oncotarget42 (2015): 44437.
52. Wang Xinjing., et al. "Melittin-induced long non-coding RNA NONHSAT105177 inhibits proliferation and migration of pancreatic ductal adenocarcinoma”. Cell Death and Disease10 (2018): 940.
53. Hu Haiyang., et al. "Effect of polypeptides in bee venom on growth inhibition and apoptosis induction of the human hepatoma cell line SMMC-7721 in-vitro and Balb/c nude mice in-vivo”. Journal of Pharmacy and Pharmacology1 (2006): 83-89.
54. Wang Jianjun., et al. "Melittin inhibits the invasion of MCF‑7 cells by downregulating CD147 and MMP‑9 expression”. Oncology Letters2 (2017): 599-604.
55. Taylor Paul M., et al. "Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway”. Oncogene37 (2002): 5765-5772.
56. Oršolić Nada. "Bee venom in cancer therapy”. Cancer and Metastasis Reviews31 (2012): 173-194.
57. Sigismund Sara., et al. "Emerging functions of the EGFR in cancer”. Molecular Oncology1 (2018): 3-20.
58. Synowiec Ewelina., et al. "UV differentially induces oxidative stress, DNA damage and apoptosis in BCR-ABL1-positive cells sensitive and resistant to imatinib”. International Journal of Molecular Sciences8 (2015): 18111-18128.
59. Russell Pamela J., et al. "Cytotoxic properties of immunoconjugates containing melittin-like peptide 101 against prostate cancer: in vitro and in vivo studies”. Cancer Immunology, Immunotherapy53 (2004): 411-421.
60. Park Hye Ji., et al. "JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin”. Journal of inflammation1 (2008): 1-13.
61. Park Hye Ji., et al. "Antiarthritic effect of bee venom: Inhibition of inflammation mediator generation by suppression of NF‐κB through interaction with the p50 subunit”. Arthritis and Rheumatism11 (2004): 3504-3515.
62. Iqbal Nida and Naveed Iqbal. "Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications”. Molecular Biology International2014 (2014).
63. Ferguson Elaine L and Ruth Duncan. "Dextrin− phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate”. Biomacromolecules6 (2009): 1358-1364.
64. Burke John E and Edward A Dennis. "Phospholipase A2 structure/function, mechanism, and signaling1”. Journal of Lipid Research50 (2009): S237-S242.
65. Six David A and Edward A Dennis. "The expanding superfamily of phospholipase A2 enzymes: classification and characterization”. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids1-2 (2000): 1-19.
66. Valentin Emmanuel and Gérard Lambeau. "What can venom phospholipases A2 tell us about the functional diversity of mammalian secreted phospholipases A2?”. Biochimie9-10 (2000): 815-831.
67. Ruiter Gerald A., et al. "Alkyl-lysophospholipids as anticancer agents and enhancers of radiation-induced apoptosis”. International Journal of Radiation Oncology* Biology* Physics2 (2001): 415-419.
68. Ruiter Gerald A., et al. "Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase–Akt/PKB survival pathway”. Anti-cancer Drugs2 (2003): 167-173.
69. Samadder Pranati., et al. "Synthesis and use of novel ether phospholipid enantiomers to probe the molecular basis of the antitumor effects of alkyllysophospholipids: Correlation of differential activation of c-Jun NH2-terminal protein kinase with antiproliferative effects in neuronal tumor cells”. Journal of Medicinal Chemistry10 (2004): 2710-2713.
70. Li Shuyu., et al. "Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression”. International Journal of Oncology5 (2005): 1329-1338.
71. Lee Hyo-Sung., et al. "Detoxification of Bee venom increases Its anti-inflammatory activity and decreases Its cytotoxicity and allergenic activity”. Applied Biochemistry and Biotechnology193 (2021): 4068-4082.
72. Yu Xiang., et al. "Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis”. Nature Communications1 (2019): 574.
73. Gajski Goran., et al. "Combined antitumor effects of bee venom and cisplatin on human cervical and laryngeal carcinoma cells and their drug resistant sublines”. Journal of Applied Toxicology12 (2014): 1332-1341.
74. Park Jung Hyun., et al. "Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-κB and AP-1-dependent MMP-9 expression”. Molecules and Cells29 (2010): 209-215.
75. Rady Islam., et al. "Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy”. Cancer Letters402 (2017): 16-31.

Citation

Citation: Monalisa Parija and Sandip K Mishra. “Attenuation of ROS Mediated Regulation of Cell Signaling by Bee Venom and Melittin in Cancer Progression" Acta Scientific Cancer Biology 7.4 (2023): 03-11.

Copyright

Copyright: © 2023 Monalisa Parija and Sandip K Mishra. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.